标题
Budesonide/Glycopyrronium/Formoterol: A Review in COPD
作者
关键词
-
出版物
DRUGS
Volume 81, Issue 12, Pages 1411-1422
出版商
Springer Science and Business Media LLC
发表日期
2021-08-03
DOI
10.1007/s40265-021-01562-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Physiology May be the Key: Cardiovascular Risk Stratification in OSA
- (2021) Bhajan Singh AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
- (2021) Arnaud Bourdin et al. ADVANCES IN THERAPY
- Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review
- (2020) Shiyuan Zhang et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS
- (2020) Chen Wang et al. ADVANCES IN THERAPY
- Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
- (2020) Gary T. Ferguson et al. ADVANCES IN THERAPY
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
- (2020) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- FUNCTIONAL RESPIRATORY IMAGING ASSESSMENT OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AND GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALERS IN PATIENTS WITH COPD
- (2020) M. van den Berge et al. CHEST
- A SCINTIGRAPHY STUDY OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN PATIENTS WITH COPD
- (2020) Omar Usmani et al. CHEST
- Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies
- (2020) Luigino Calzetta et al. Expert Review of Respiratory Medicine
- Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for COPD: A Randomized, Double-Blind, Multi-Center Parallel-Group Study
- (2020) Fernando J. Martinez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD
- (2019) Luigino Calzetta et al. CHEST
- Pharmacokinetics and Tolerability of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate and Glycopyrronium/Formoterol Fumarate Dihydrate Metered Dose Inhalers in Healthy Chinese Adults: A Randomized, Double-blind, Parallel-group Study
- (2019) Qian Chen et al. CLINICAL THERAPEUTICS
- Glycopyrronium/Formoterol: A Review in COPD
- (2019) Zaina T. Al-Salama et al. DRUGS
- Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD
- (2019) Leonard J. Dunn et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD
- (2019) Masakazu Ichinose et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study
- (2019) Masakazu Ichinose et al. International Journal of Chronic Obstructive Pulmonary Disease
- The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults
- (2018) Patrick Darken et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
- (2018) Gary T Ferguson et al. Lancet Respiratory Medicine
- Budesonide/Formoterol Turbuhaler®
- (2012) Lesley J. Scott DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now